机译:永久性CNI治疗可防止致敏宿主发生肾脏异体移植排斥反应,可通过调节性T细胞替代
Institute of Medical Biochemistry and Molecular Biology University of Rostock Germany;
Institute of Medical Immunology Charité—University Medicine Berlin Germany;
Research Center of Immunosciences Charité—University Medicine Berlin Germany;
Department of Cellular and Molecular Immunology University of Goettingen Medical School Germany;
Institute of Pathology University of Rostock Germany;
Berlin-Brandenburg Center for Regenerative Therapies (BCRT) Charité—University Medicine Berlin Germany;
Kidney Transplantation Research Unit Department of Nephrology and Internal Intensive Care Medicine Charité—University Medicine Berlin Germany;
T cell depleting mAb; calcineurin inhibitor; memory T cells; regulatory T cells; kidney transplantation;
机译:可以用调节性T细胞代替用于预防致敏宿主中肾脏同种异体移植排斥的永久性CNI治疗。
机译:通过调节性T细胞免疫疗法长期预防慢性同种异体移植排斥反应涉及宿主表达Foxp3的T细胞。
机译:监管T细胞免疫疗法的长期预防慢性同种异体移植抑制涉及宿主福索普3表达的T细胞。
机译:基于成像标志物和实验室生物标志物的肾脏异体移植急性排斥检测CAD系统
机译:T细胞介导的炎症是定型的:小鼠迟发型超敏反应和小鼠T细胞介导的肾同种异体移植排斥反应具有共同的分子机制。
机译:通过扩增Foxp3 + CD4 + CD25 +调节性T细胞来预防同种异体排斥反应
机译:预防用于预防肾同种异体移植物排斥反应的敏化宿主的永久性CNI治疗可以通过调节T细胞取代